Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors

Impact on decision making framework for medicine purchasing in Chinese public hospital decision-making: determining the value of five dipeptidyl peptidase 4 (DPP-4) inhibitors

Abstract Background Medicine purchasing in Chinese public hospitals is decided by the hospital Pharmacy Management Committee (PMC), that is complex, subjective and requires efficient approaches to ensure transparency and consistency for the factors being considered. This study aimed to use the Evide...

Full description

Bibliographic Details
Main Authors: Yun Bao, Bei Gao, Min Meng, Bin Ge, Yan Yang, Chunchun Ding, Bingyin Shi, Limin Tian
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Health Services Research
Subjects:
Evidence and Value: Impact on Decision Making (EVIDEM) framework
Multi-criteria decision analysis (MCDA)
Hospital-based health technology assessment (HB-HTA)
Online Access:https://doi.org/10.1186/s12913-021-06827-0

Internet

https://doi.org/10.1186/s12913-021-06827-0

Similar Items